Dr. Jingyi Wu, Assistant Professor of Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School, has been awarded the prestigious National Cancer Institute (NCI) Transition Career...
A new collaborative study led by scientists from the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute (DFCI), and Beth Israel Deaconess Medical Center (BIDMC) has uncovered how two...
A collaborative team led by Dr. Jingyi Wu at the Dana-Farber Cancer Institute and Massachusetts General Hospital has revealed how epigenetic and genetic forces drive the deadly progression of IDH...
